Back to Search Start Over

Integrated transcriptomics uncovers an enhanced association between the prion protein gene expression and vesicle dynamics signatures in glioblastomas.

Authors :
Boccacino, Jacqueline Marcia
dos Santos Peixoto, Rafael
Fernandes, Camila Felix de Lima
Cangiano, Giovanni
Sola, Paula Rodrigues
Coelho, Bárbara Paranhos
Prado, Mariana Brandão
Melo-Escobar, Maria Isabel
de Sousa, Breno Pereira
Ayyadhury, Shamini
Bader, Gary D.
Shinjo, Sueli Mieko Oba
Marie, Suely Kazue Nagahashi
da Rocha, Edroaldo Lummertz
Lopes, Marilene Hohmuth
Source :
BMC Cancer; 2/13/2024, Vol. 24 Issue 1, p1-17, 17p
Publication Year :
2024

Abstract

Background: Glioblastoma (GBM) is an aggressive brain tumor that exhibits resistance to current treatment, making the identification of novel therapeutic targets essential. In this context, cellular prion protein (PrP<superscript>C</superscript>) stands out as a potential candidate for new therapies. Encoded by the PRNP gene, PrP<superscript>C</superscript> can present increased expression levels in GBM, impacting cell proliferation, growth, migration, invasion and stemness. Nevertheless, the exact molecular mechanisms through which PRNP/PrP<superscript>C</superscript> modulates key aspects of GBM biology remain elusive. Methods: To elucidate the implications of PRNP/PrP<superscript>C</superscript> in the biology of this cancer, we analyzed publicly available RNA sequencing (RNA-seq) data of patient-derived GBMs from four independent studies. First, we ranked samples profiled by bulk RNA-seq as PRNP<superscript>high</superscript> and PRNP<superscript>low</superscript> and compared their transcriptomic landscape. Then, we analyzed PRNP<superscript>+</superscript> and PRNP<superscript>-</superscript> GBM cells profiled by single-cell RNA-seq to further understand the molecular context within which PRNP/PrP<superscript>C</superscript> might function in this tumor. We explored an additional proteomics dataset, applying similar comparative approaches, to corroborate our findings. Results: Functional profiling revealed that vesicular dynamics signatures are strongly correlated with PRNP/PrP<superscript>C</superscript> levels in GBM. We found a panel of 73 genes, enriched in vesicle-related pathways, whose expression levels are increased in PRNP<superscript>high</superscript>/PRNP<superscript>+</superscript> cells across all RNA-seq datasets. Vesicle-associated genes, ANXA1, RAB31, DSTN and SYPL1, were found to be upregulated in vitro in an in-house collection of patient-derived GBM. Moreover, proteome analysis of patient-derived samples reinforces the findings of enhanced vesicle biogenesis, processing and trafficking in PRNP<superscript>high</superscript>/PRNP<superscript>+</superscript> GBM cells. Conclusions: Together, our findings shed light on a novel role for PrP<superscript>C</superscript> as a potential modulator of vesicle biology in GBM, which is pivotal for intercellular communication and cancer maintenance. We also introduce GBMdiscovery, a novel user-friendly tool that allows the investigation of specific genes in GBM biology. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
14712407
Volume :
24
Issue :
1
Database :
Complementary Index
Journal :
BMC Cancer
Publication Type :
Academic Journal
Accession number :
175389815
Full Text :
https://doi.org/10.1186/s12885-024-11914-6